Viewing Study NCT06604247



Ignite Creation Date: 2024-10-26 @ 3:40 PM
Last Modification Date: 2024-10-26 @ 3:40 PM
Study NCT ID: NCT06604247
Status: COMPLETED
Last Update Posted: None
First Post: 2024-09-17

Brief Title: The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients
Sponsor: None
Organization: None

Study Overview

Official Title: The Association Between CBT-I Dose and Innate Immunity in Insomnia and Fatigue in Prostate Cancer Patients
Status: COMPLETED
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The objective of this project is to test the association between Cognitive Behavioral Therapy for Insomnia dose number of sessions severity of cancer related fatigue and levels of innate immunity biomarkers Ultimately this research will help to develop a better understanding of the underlying mechanisms of cancer related fatigue
Detailed Description: Cancer-related fatigue CRF and insomnia are prevalent among cancer patients and have been linked to decreases in quality of life and poorer overall survivorship Currently the mechanisms underlying CRF are not well understood which has led to treatments that are only moderately effective In addition when compared to Cognitive Behavioral Therapy for Insomnia CBT-I in the general population the treatment outcomes in CBT-I with cancer patients are subpar and as such this study will evaluate whether dose of CBT-I is effective in ameliorating CRF

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None